Sign Up to like & get
recommendations!
0
Published in 2020 at "Therapeutic Drug Monitoring"
DOI: 10.1097/ftd.0000000000000773
Abstract: BACKGROUND A modified-release version of tacrolimus, LCP-tacrolimus (LCPT; Envarsus XR, Veloxis Pharmaceuticals), has been licensed in the United States for prophylaxis of organ rejection in de novo kidney transplant patients. As tacrolimus has a narrow…
read more here.
Keywords:
time;
blood;
food;
lcp tacrolimus ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Clinical Transplantation"
DOI: 10.1111/ctr.14941
Abstract: The influence of converting to once daily, extended‐release LCP‐Tacrolimus (Tac) for those with high tacrolimus variability in kidney transplant recipients (KTRs) is not well‐studied.
read more here.
Keywords:
lcp tacrolimus;
high tacrolimus;
kidney transplant;
release ... See more keywords